1Rossing P.Diabetic nephropathy- world wild epidemic and effects of current treatmentonnatural history[J] Curr Diab Rep, 2006,6(6):497.
2Thomas MC, Atkins RC.Blood pressure lowering for the prevention and treatment of diabetic kidney disease [J ]. Drugs, 2006,66(17) :2213.
3Makino H, Doi K, Hiuge A, et al. Impaired flowmediated vascodilatation and insulin resistance in type 2 diabetic patients with albuminuria[J] .Diabetes Res Clin Pract, 2008,79(1) : 177.
7Tessari P, Kiwanuka E, Barazzoni R, et al .Diabetic nephropathy is associated with increased albumin and fibrinogen production in patients with type 2 diabetes [J ]. Diabetologia ,2006,49(8) :1 955.
5[2]Imperatore G,Hanson RL,Pettitt DJ.Sib-pair linkage analysis for susceptibility genes for microvascular complications among pima indians with type 2 diabetes[J].Diabetes,1998,47(5):821-830.
6[1]Kuller LH, TracyRP, Shaten J, et al. Relation of C reactive protein and coronary heart disease in the MFIT nested case control study[J ]. Am J Epidemiol 1996; 144:537 - 547.
7[2]Haffner SM, Gonzale ZC, Miettinen H, et al. A prospective analysia of the HOMA model. The mecicocity diabetetes study[J ].Diabetes Care 1996;19:1138- 1441.
8[4]ReavenGM. Insulin resistance, hyperinsulinemia and hypertriglyceridemia in etiology and clinical course of hypertension [ J ].Am J Med 1991;90:7s- 12s.
9[5]Pickup JC, Crook MA. Is type 2 diabetes mellitus a disease of the innate immune system? Diabetologia 1998; 41: 1241 -1248.
10[6]Pradan AD, Manson JE, Rifai N, et al. C reactive protein,inter leukin6, and risk of developing type 2 diabetes mellitus J AMA 2001;286:327- 334.
1American Diabetes Association and National Institute of Diabetes, Digestive and kidney diseases. The prevention or delay of type 2 diabetes[J]. Diabetes Care, 2002, 25(4) : 742.
2Shaft T, Appel L J, Miller ER, et al. Changes in Serum Potassium Mediate Thiazide-Induced Diabetes [J]. Hypertension, 2008, 52(6): 1 022.
3Matayoshi T, Kamide K, Takiuchi S, et al. Relationship between insulin resistance and the renin-angiotensin sys tern: analysis for patients with essential and renovaseular hypertension[J]. Clin ExpHypertens, 2007, 29(7): 479.
4Scheen AJ. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system[J]. Drugs, 2004,64(22): 2 537.
5Jiang X, Sheng H, Li J, et al.Association between renin-an giotensin system gene polymorphism and essential hypertension: a community-based study[J]. J Hum Hypertens, 2009, 23(3): 176.
6Scheen AJ. Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms[J]. Diabetes Metab, 2004, 30(6) : 498.
7Richey JM, Ader M, Moore D, et al. Angiotensin Ⅱ induces insulin resistance independent of changes in interstitial insulin[J]. Am JPhysiol, 1999, 277 (5 pt 1 ) : E920.
8Chandran M, Phillips SA, Ciaraldi T, et al. Adiponeetin: more than just another fat cell hormone?[J]. Diabetes Care, 2003, 26(8): 2 442.
9Matayoshi T,Kamide K,Takiuchi S,et al. Relationship between insulin resistance and the renin-angiotensin system: analysis for patients with essential and renovascularhypertension [J]. Clin Exp Hypertens,2007,29(7) :479.
10Scheen AJ. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system [J]. Drugs,2004,64(22) :2537.
